Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease

AIM: To assess tumor necrosis factor-α (TNF-α), infliximab (IFX) concentrations, and antibodies against IFX molecules in patients with inflammatory bowel disease (IBD) who develop loss of response, side effects, or allergic reaction during anti TNF-α therapy. METHODS: Blood samples of 36 patients wi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pallagi-Kunstár, Éva, Farkas, Klaudia, Szepes, Zoltán, Nagy, Ferenc, Szűcs, Mónika, Kui, Róbert, Gyulai, Rolland, Bálint, Anita, Wittmann, Tibor, Molnár, Tamás
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Co., Limited 2014
Gaiak:
Brief Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4009537/
https://ncbi.nlm.nih.gov/pubmed/24833846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i17.5031
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak